The Latest Cardiac and Vascular News
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for its first quarter ended March 31, 2019. Recent Financial Highlights and Business Accomplishments: Revenue totaled $3.0 million during the first quarter of 2019, including sale and installation of nine […]
SANTA CRUZ, Calif., May 08, 2019 (GLOBE NEWSWIRE) — Murj, the digital healthcare company for Software-as-a-Service (SaaS) cardiac implantable electronic device (CIED) management announced today the availability of Murj Analytics. This new offering features powerful intelligence for cardiac device clinicians seeking to provide comprehensive population management through improved clinical, workforce […]
WALTHAM, Mass., May 08, 2019 (GLOBE NEWSWIRE) — Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced its financial results for the quarter ended March 31, 2019, and recent events. Recent Events PATENCY-2 Trial Misses Statistical […]
SOUTH SAN FRANCISCO, Calif., May 07, 2019 (GLOBE NEWSWIRE) — MyoKardia, a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of serious cardiovascular diseases, today announced the award of $750,000 divided among three innovative research projects through the first cycle of its MyoSeeds™ Research Grants Program (“MyoSeeds”). MyoSeeds is […]
SAN CARLOS, Calif., May 08, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the AVANCE™ steerable introducer product family, designed for introducing various cardiovascular catheters into the heart, including […]
ST. LOUIS, May 8, 2019 /PRNewswire/ — SentiAR, a medical device startup transforming the cardiac ablation procedures, today announced that industry expert Berk Tas has joined the company as CEO and president. Tas brings to SentiAR over a decade in the healthcare medical device industry at both large organizations and startups. Tas has […]
PLANO, Texas, May 8, 2019 /PRNewswire/ — MediLynx Cardiac Monitoring, LLC today announced new research connecting short episodes of Atrial Fibrillation called micro-AF (4 beats <29) with the presentation of clinical AF (>30 seconds). The study showed that 83% of patients with micro-AF also had a clinical AF episode during prolonged registration, and […]
LONDON, May 8, 2019 /PRNewswire/ — Radcliffe Group Ltd (“RG”) announces Professor Andrew Coats (recently Academic Vice President, Monash University and University of Warwick) as Non-Executive Chairman and Dr. Gregory Guillory as Chief Scientific Officer, effective on April 1, 2019. Professor Andrew Coats (top right) is a world-renowned Australian–British academic cardiologist who has a particular interest in the management of heart failure. His research […]
VANCOUVER, May 8, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today reported financial results for its first quarter ended March 31, 2019 and commented on recent accomplishments and plans. “2019 is off to a strong start with first quarter revenues up 16% year-over-year in […]
MINNEAPOLIS, May 8, 2019 /PRNewswire/ — At Heart Rhythm 2019, the Heart Rhythm Society’s 40th Annual Scientific Sessions, Preventice Solutions will present clinical data validating its BodyGuardian® Remote Monitoring System with the BeatLogic™ deep learning platform. This technology leverages machine learning and artificial intelligence (AI) for detection of atrial fibrillation (AF) and was validated using […]
